Tweedy, Browne Co All Funds (US) recent buys & sells (2021 Q1)
B. Tweedy, Ch. Browne
Tweedy, Browne Co All Funds (US) Portfolio Changes
Purchase & sale details
- Portfolio value:
- $3.44B~ (+$218M~)
- Previous value:
- $3.22B~
- # of changes:
- 48
- New positions:
- 2
- Reported for:
- 31 Mar 2021 (Q1)
- Latest filing date:
- 07 May 2021
Tweedy, Browne Co All Funds (US) has disclosed a total of 48 changes to the portfolio in the (2021 Q1) SEC report(s): increased the number of shares of 3, bought 2 totally new, decreased the number of shares of 39 and completely sold out 4 position(s).
What stocks did Tweedy, Browne Co All Funds (US) buy in 2021 Q1?
During 2021 Q1 Tweedy, Browne Co All Funds (US) has purchased 5 securities: (BABA) Alibaba Group Holding Ltd (added shares +67.76%), (FMS) Fresenius Medical Care Corp (new buy), (CNXC) Concentrix Corp (added shares +42.35%), (PGR) Progressive Corp (new buy) and (GSK) GlaxoSmithKline PLC ADR (added shares +26.11%).
What did Tweedy, Browne Co All Funds (US) invest in during 2021 Q1?
In the 2021 Q1 report(s) the following changes have been made to the top investments: (BRK-A) Berkshire Hathaway Inc (reduced shares -0.30%), (JNJ) Johnson & Johnson (reduced shares -1.52%), (GOOGL) Alphabet Inc, CL-A (reduced shares -0.19%), (BABA) Alibaba Group Holding Ltd (added shares +67.76%) and (GOOG) Alphabet Inc, CL-C (reduced shares -0.17%).
48 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Fresenius Medical Care Corp
|
new
|
+530,064
|
530,064
|
+0.57%
|
$36.88
|
-37.43%($23.08)
|
0.57%
|
2021 Q1
|
~0.25 years
|
|
|
|
Progressive Corp
|
new
|
+136,403
|
136,403
|
+0.38%
|
$95.61
|
+128.64%($218.59)
|
0.38%
|
2021 Q1
|
~0.25 years
|
|
|
|
Alibaba Group Holding Ltd
|
+67.76%
|
+447,895
|
1,108,910
|
+2.95%
|
$226.73
|
-52.35%($108.03)
|
7.32%
|
2020 Q4
|
~0.50 years
|
|
|
|
Concentrix Corp
|
+42.35%
|
+30,375
|
102,092
|
+0.13%
|
$149.72
|
-80.96%($28.51)
|
0.44%
|
2020 Q4
|
~0.50 years
|
|
|
|
GlaxoSmithKline PLC ADR
|
+26.11%
|
+31,915.2
|
154,159.2
|
+0.04%
|
$44.61
|
+12.67%($50.26)
|
0.20%
|
2013 Q2*
|
> 8 years
|
|
|
|
AbbVie Inc
|
-0.16%
|
-640
|
391,595
|
-0%
|
$108.22
|
+143.10%($263.08)
|
1.23%
|
2020 Q2
|
~1.00 year
|
|
|
|
Alphabet Inc, CL-C
|
-0.17%
|
-3,900
|
2,333,360
|
-0.01%
|
$103.43
|
+230.34%($341.68)
|
7.02%
|
2014 Q1
|
~7.25 years
|
|
|
|
Autoliv Inc
|
-0.18%
|
-2,050
|
1,131,828
|
-0.01%
|
$92.80
|
+25.39%($116.36)
|
3.06%
|
2020 Q1
|
~1.25 years
|
|
|
|
Alphabet Inc, CL-A
|
-0.19%
|
-4,780
|
2,569,940
|
-0.02%
|
$103.13
|
+234.56%($345.02)
|
7.71%
|
2014 Q2
|
~7.00 years
|
|
|
|
Bank of America Corp
|
-0.24%
|
-4,760
|
1,957,367
|
-0.01%
|
$38.69
|
+51.24%($58.52)
|
2.20%
|
2020 Q3
|
~0.75 years
|
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted. 2013 Q2 is the earliest period we have data for, so "2013 Q2*" means "2013 Q2 or earlier".